Dave Hava

Company: Synlogic, Inc.

Job title: CSO

Seminars:

Development of a Synthetic Biotic for the Treatment of Phenylketonuria 2:15 pm

• Phenylketonuria is a rare inherited disorder of Phenylalanine metabolism, with significant risk of neurocognitive impairment and high unmet need • Our team at Synlogic has developed SYNB168, an engineered Synthetic Biotic to consume Phe in the GI tract that demonstrated fasting plasma Phe lowering in patients with PKU • The SYNB1618 clinical data validate…Read more

day: Day One – Track B – 2